Free Trial

Rockwell Medical (RMTI) Competitors

Rockwell Medical logo
$1.21 -0.01 (-0.82%)
Closing price 04:00 PM Eastern
Extended Trading
$1.23 +0.02 (+1.24%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RMTI vs. ABT, ISRG, BSX, SYK, MDT, BDX, IDXX, EW, RMD, and DXCM

Should you be buying Rockwell Medical stock or one of its competitors? The main competitors of Rockwell Medical include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), IDEXX Laboratories (IDXX), Edwards Lifesciences (EW), ResMed (RMD), and DexCom (DXCM). These companies are all part of the "health care equipment" industry.

Rockwell Medical vs. Its Competitors

Rockwell Medical (NASDAQ:RMTI) and Abbott Laboratories (NYSE:ABT) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.

23.3% of Rockwell Medical shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 1.9% of Rockwell Medical shares are held by insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Rockwell Medical has a beta of 1.73, suggesting that its stock price is 73% more volatile than the S&P 500. Comparatively, Abbott Laboratories has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500.

Abbott Laboratories has a net margin of 32.43% compared to Rockwell Medical's net margin of -2.38%. Abbott Laboratories' return on equity of 18.32% beat Rockwell Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Rockwell Medical-2.38% -6.79% -3.77%
Abbott Laboratories 32.43%18.32%10.71%

In the previous week, Abbott Laboratories had 50 more articles in the media than Rockwell Medical. MarketBeat recorded 53 mentions for Abbott Laboratories and 3 mentions for Rockwell Medical. Abbott Laboratories' average media sentiment score of 1.50 beat Rockwell Medical's score of 0.42 indicating that Abbott Laboratories is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rockwell Medical
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Abbott Laboratories
49 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Rockwell Medical currently has a consensus price target of $4.00, suggesting a potential upside of 230.58%. Abbott Laboratories has a consensus price target of $145.39, suggesting a potential upside of 8.80%. Given Rockwell Medical's higher probable upside, equities research analysts plainly believe Rockwell Medical is more favorable than Abbott Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rockwell Medical
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.75
Abbott Laboratories
0 Sell rating(s)
4 Hold rating(s)
16 Buy rating(s)
2 Strong Buy rating(s)
2.91

Abbott Laboratories has higher revenue and earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rockwell Medical$101.49M0.41-$480K-$0.06-20.17
Abbott Laboratories$41.95B5.54$13.40B$7.9816.75

Summary

Abbott Laboratories beats Rockwell Medical on 14 of the 17 factors compared between the two stocks.

Get Rockwell Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RMTI vs. The Competition

MetricRockwell MedicalMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$42.01M$10.98B$6.16B$10.58B
Dividend YieldN/A1.83%5.66%4.69%
P/E Ratio-20.1714.7265.0423.37
Price / Sales0.4128.76612.06135.37
Price / Cash9.6525.6126.3031.10
Price / Book1.203.4812.876.67
Net Income-$480K$210.63M$3.30B$276.23M
7 Day Performance-4.72%2.52%4.80%3.31%
1 Month Performance-25.31%2.31%8.11%10.76%
1 Year Performance-66.76%-6.64%75.85%33.58%

Rockwell Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RMTI
Rockwell Medical
3.3037 of 5 stars
$1.21
-0.8%
$4.00
+230.6%
-66.5%$42.01M$101.49M-20.17300Positive News
Short Interest ↑
ABT
Abbott Laboratories
4.9577 of 5 stars
$133.01
-0.4%
$145.22
+9.2%
+19.4%$232.44B$43.11B16.67114,000Positive News
ISRG
Intuitive Surgical
4.952 of 5 stars
$439.22
-0.4%
$595.95
+35.7%
-6.1%$158.13B$8.35B61.2615,638Positive News
Analyst Upgrade
BSX
Boston Scientific
4.9269 of 5 stars
$96.89
-1.3%
$118.38
+22.2%
+15.1%$145.48B$16.75B57.6753,000Analyst Downgrade
Analyst Revision
SYK
Stryker
4.9613 of 5 stars
$369.02
flat
$430.33
+16.6%
+5.5%$141.08B$22.60B48.8853,000Positive News
MDT
Medtronic
4.8316 of 5 stars
$94.00
-0.2%
$102.27
+8.8%
+10.6%$120.85B$33.54B25.8995,000Positive News
Analyst Downgrade
BDX
Becton, Dickinson and Company
4.9441 of 5 stars
$183.85
-0.4%
$213.09
+15.9%
-18.7%$52.91B$20.18B33.0774,000Positive News
IDXX
IDEXX Laboratories
4.2807 of 5 stars
$630.56
-0.3%
$649.44
+3.0%
+32.1%$50.58B$3.90B52.5011,000Positive News
EW
Edwards Lifesciences
4.8302 of 5 stars
$77.25
+1.3%
$86.61
+12.1%
+17.6%$44.77B$5.44B11.1115,800Positive News
Short Interest ↓
RMD
ResMed
4.5522 of 5 stars
$271.22
+0.4%
$294.20
+8.5%
+19.0%$39.57B$5.15B28.5210,600Positive News
DXCM
DexCom
4.9599 of 5 stars
$66.46
-1.0%
$99.11
+49.1%
-1.6%$26.31B$4.03B46.1510,300

Related Companies and Tools


This page (NASDAQ:RMTI) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners